HAILEY BRICKMAN: Open Payments
NPI 1598315947 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,067 in 328 payments from 21 companies in 2025. Trend: 2023 $19,602 · 2024 $11,637 · 2025 $41,067
Speaker / faculty: $21,250Food & beverage: $8,566Consulting: $7,338Travel & lodging: $3,903Education: $10
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 52 | $16,158 |
| ABBVIE INC. | 61 | $14,437 |
| Arcutis Biotherapeutics, Inc. | 36 | $3,111 |
| Regeneron Healthcare Solutions, Inc. | 10 | $1,342 |
| Galderma Laboratories, L.P. | 39 | $1,178 |
| UCB, Inc. | 18 | $641 |
| Novartis Pharmaceuticals Corporation | 18 | $635 |
| Botanix SB Inc | 3 | $622 |
| GENZYME CORPORATION | 12 | $574 |
| Incyte Corporation | 12 | $468 |
Products named: EBGLYSS, SKYRIZI, Zoryve, DUPIXENT, NEMLUVIO, Bimzelx, SOFDRA, COSENTYX.
Industry payments across NY — which companies pay providers there.
